Company intelligence / Profile preview

Liteling

Suzhou, Jiangsu, China
Ownership
Private
Development stage
Other
01

Overview

Liteling is a synthetic biology company that leverages its proprietary Enzyme-Catalyzed Synthesis (ECS) platform to produce high-value biochemicals. Based in Suzhou, China, the company focuses on the green manufacturing of ingredients such as Nicotinamide Mononucleotide (NMN), functional peptides, and specialized amino acids. Liteling's technology replaces traditional chemical synthesis with enzymatic processes, offering higher purity and lower environmental impact for the pharmaceutical, nutraceutical, and cosmetic sectors. The company operates as both a product manufacturer and a CDMO partner for complex molecule synthesis. By integrating computational biology and enzyme engineering, Liteling aims to scale the production of rare and difficult-to-synthesize natural compounds. Its flagship product, NMN, is widely used in the longevity and metabolic health markets.

Therapeutic areas
DermatologyOtherMetabolic Disorders
Modalities
Small moleculePeptides
Industry
Non-Drug Biotech

Beyond the preview

Go deeper on Liteling.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liteling.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call